| Price | 77.00p on 21-11-2025 at 19:40:05 |
|---|---|
| Change | -1.50p -1.91% |
| Buy | 78.00p |
| Sell | 76.00p |
| Last Trade: | Sell 10,086.00 at 76.5588p |
| Day's Volume: | 4,578,698 |
| Last Close: | 77.00p |
| Open: | 78.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 76.00p - 78.70p |
| 52wk Range: | 27.25p - 83.20p |
| Market Capitalisation: | £333.92m |
| VWAP: | 77.23281p |
| Shares in Issue: | 433.66m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 10,086 | 76.5588p | Ordinary |
16:29:14 - 21-Nov-25 |
| Buy* | 25 | 78.00p | Ordinary |
16:29:07 - 21-Nov-25 |
| Sell* | 3,919 | 76.555p | Ordinary |
16:29:04 - 21-Nov-25 |
| Buy* | 25,863 | 77.30p | Ordinary |
16:28:25 - 21-Nov-25 |
| Sell* | 30,000 | 76.22p | Ordinary |
16:28:12 - 21-Nov-25 |
| Buy* | 3,757 | 77.188p | Ordinary |
16:28:07 - 21-Nov-25 |
| Buy* | 3,886 | 77.188p | Ordinary |
16:27:49 - 21-Nov-25 |
| Buy* | 10,000 | 77.2961p | Ordinary |
16:27:35 - 21-Nov-25 |
| Sell* | 20,000 | 76.4288p | Ordinary |
16:27:20 - 21-Nov-25 |
| Buy* | 750 | 77.30p | Ordinary |
16:26:49 - 21-Nov-25 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 3rd Nov 2025 8:24 am | RNS | Completion of Placing and TVR |
| 27th Oct 2025 5:39 pm | RNS | Block Listing Six Monthly Return |
| 27th Oct 2025 7:00 am | RNS | Avacta presents preclinical data at AACR-NCI-EORTC |
| 23rd Oct 2025 5:00 pm | RNS-R | Notice of Investor Presentation |
| 20th Oct 2025 7:01 am | RNS | Equity fundraise of £16 million |
| 20th Oct 2025 7:00 am | RNS | Avacta Presents Phase 1a Data for Faridoxorubicin |
| 13th Oct 2025 7:00 am | RNS | Avacta to present data at EORTC-NCI-AACR |
| 30th Sep 2025 7:00 am | RNS | Interim Half Year Results 2025 |
| 15th Sep 2025 7:00 am | RNS | Notice of Interim Results |
| 9th Sep 2025 7:00 am | RNS-R | Shortlisted for AIM Awards Technology of the Year |
